Dr. Patterson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 1st St SW
# Mayo
Rochester, MN 55905Phone+1 507-284-2511
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Residency, Pediatrics, 1992 - 1993
National Institute of Neurological Disorders and Stroke, Warren Grant Magnusson Clinical Center, National Institutes of HealthFellowship, Intramural Research, 1990 - 1992
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Child Neurology, 1988 - 1990- Royal Children's HospitalMedical Registrar, Pediatrics, 1988 - 1988
- University of QueenslandClinical Lecturer, Neurology, 1986 - 1987
- Royal Brisbane HospitalMedical Registrar, Internal Medicine, Nephrology, Hematology/Oncology, 1984 - 1985
- Royal Children's Hospital, Royal Brisbane HospitalInternship, 1982
- University of QueenslandMB BS, Medicine , First Class Honours, 1976 - 1981
The University of Queensland Medical SchoolClass of 1981
Certifications & Licensure
ND State Medical License 2014 - 2026
MN State Medical License 1990 - 2025
WI State Medical License 2013 - 2025
NY State Medical License 2000 - 2014- American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology
- American Board of Psychiatry and Neurology Neurodevelopmental Disabilities
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2002-2014
- Top Doctors: New York Metro Area Castle Connolly, 2003-2007
- New York Magazine: Top Doctors Castle Connolly, 2002-2007
- Join now to see all
Clinical Trials
- Longitudinal Study of Cognition With Niemann-Pick Disease, Type C Start of enrollment: 2011 Mar 01
- Early Access Program With Arimoclomol in US Patients With NPC
Roles: Principal Investigator, Contact
- GM1 and GM2 Gangliosidosis PROspective Neurological Disease TrajectOry Study (PRONTO) Start of enrollment: 2022 Feb 22
Roles: Contact
Publications & Presentations
PubMed
- A natural history study of pediatric patients with early onset of GM1 gangliosidosis, GM2 gangliosidoses, or gaucher disease type 2 (RETRIEVE).Bénédicte Héron, Spyros Batzios, Eugen Mengel, Roberto Giugliani, Marc Patterson
Orphanet Journal of Rare Diseases. 2024-12-05 - Assessment of the reliability, responsiveness, and meaningfulness of the scale for the assessment and rating of ataxia (SARA) for lysosomal storage disorders.Julien Park, Tatiana Bremova-Ertl, Marion Brands, Tomas Foltan, Matthias Gautschi
Journal of Neurology. 2024-10-01 - Frontiers in congenital disorders of glycosylation consortium, a cross-sectional study report at year 5 of 280 individuals in the natural history cohort.Christina Lam, Fernando Scaglia, Gerard T Berry, Austin Larson, Kyriakie Sarafoglou
Molecular Genetics and Metabolism. 2024-08-01
Press Mentions
- Azafaros Receives FDA's IND Clearance and Fast Track Designation for Lead Asset AZ-3102January 5th, 2023
- What Is Niemann-Pick Disease Type C (NPC)?April 27th, 2022
- CytRx Comments on Orphazyme’s Promising 24-Month Interim Trial Results of Arimoclomol for Niemann-Pick Disease Type CJune 30th, 2021
- Join now to see all
Grant Support
- Training &EducationNational Institute Of Neurological Disorders And Stroke2009–2011
- Longitudinal Study Of Cognition In Subjects With Niemann-Pick Disease, Type CNational Institute Of Neurological Disorders And Stroke2009–2011
Committees
- Member, ABPN -Neurology Part C Examination Committee 2012 - 2018
- Member, Chair, ABPN - Neurodevelopmental Disabilities Recertification Committee 2001 - 2010
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
